新的研究表明,对睡眠性脑膜炎的个人化CPAP治疗可显著改变心脏风险。 New study suggests personalized CPAP treatment for sleep apnea can vary heart risk significantly.

Mass General Brigham在《欧洲心脏杂志》上进行的一项新研究指出,对睡眠性脑膜炎进行个人化的CPAP治疗可降低心血管风险。 A new study from Mass General Brigham in the European Heart Journal suggests personalized CPAP treatment for sleep apnea could reduce cardiovascular risks. 研究人员对3 549名患者进行了分析,发现CPAP将高风险患者的心脏病风险降低17%,但将低风险患者的风险提高22%。 Analyzing 3,549 patients, researchers found CPAP lowers heart risks by 17% for high-risk patients but increases risk by 22% for low-risk ones. 这突出表明,需要针对妨碍睡眠的睡前膜进行量身定制的治疗,以改善心脏健康。 This highlights the need for tailored treatments for obstructive sleep apnea to improve heart health.